Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP5541 in Advanced Prostate Cancer (Phase II, Open-label, Multi-cohort)
CTR20255239Phase 2Active
- Sponsor
- 不适用/ 安斯泰来（中国）投资有限公司
- Start
- Mar 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abiraterone decanoate in prostate adenocarcinoma, sponsored by 不适用/ 安斯泰来（中国）投资有限公司. Started Mar 2026; status: active.
02
Drugs
abiraterone decanoate
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on CTR20255239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255239.